CellR4 2021; 9: e3130
DOI: 10.32113/cellr4_20214_3130

Autologous Bone Marrow Aspirate Stem Cell Concentrate (BMAC) for treatment of patients with Fontaine stages III-IV peripheral arterial disease: a pilot safety and feasibility study

CellR4 2021; 9: e3132
DOI: 10.32113/cellr4_20214_3132

Safety and efficacy of systemically administered autologous Gold-Induced Cytokines (GOLDIC®)

CellR4 2021; 9: e3093
DOI: 10.32113/cellr4_20213_3093

The pancreatic islet: a micro-organ in control

CellR4 2021; 9: e3083
DOI: 10.32113/cellr4_20213_3083

Why pancreatic islets should be regarded and regulated like organs

CellR4 2021; 9: e3058
DOI: 10.32113/cellr4_20212_3058

The role of Th17 cells in SARS-CoV-2 infection: implementation for the therapy of severe COVID-19 cases

CellR4 2021; 9: e3060
DOI: 10.32113/cellr4_20212_3060

Adipose-derived Stromal Vascular Matrix (SVM): a new paradigm in regenerative medicine

CellR4 2020; 8: e2986
DOI: 10.32113/cellr4_202012_2986

Brown adipose tissue transplantation as a promising approach for insulin-independent reversal of type 1 diabetes: animal studies and clinical perspectives

CellR4 2020; 8: e2955
DOI: 10.32113/cellr4_202010_2955

Human islet distribution during COVID-19 pandemic: the impact on diabetes research

CellR4 2020; 8: e2957
DOI: 10.32113/cellr4_202010_2957

Islet cell transplantation: the effects of COVID-19 pandemic

CellR4 2020; 8: e2943
DOI: 10.32113/cellr4_202010_2943

GLP-1 receptor agonists can reverse immunosuppression-induced beta-cell dysfunction